Hanns‐Detlev Harich

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Mohamad Mohty, Evangelos Terpos, María‐Victoria Mateos et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 89 citations · Full text

Medicine, Hematology, Pharmacoeconomics +14

A prospective multicenter phase II study of oral and i.v. vinorelbine plus trastuzumab as first-line therapy in HER2-overexpressing metastatic breast cancer

Volker Heinemann, Dorit Di Gioia, Ursula Vehling‐Kaiser et al. · Annals of Oncology · 2010 · 28 citations

Medicine, Oncology, Pharmacology +14

Trastuzumab in advanced breast cancer – a decade of experience in Germany

Christian Jackisch, Winfried Schoenegg, Dietmar Reichert et al. · BMC Cancer · 2014 · 14 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Antiemetic prophylaxis and frequency of chemotherapy-induced nausea and vomiting in palliative first-line treatment of colorectal cancer patients: the Northern Bavarian IVOPAK I Project

Sonja Koch, Axel Wein, Jürgen Siebler et al. · Supportive Care in Cancer · 2013 · 13 citations

Medicine, Oncology, Pharmacology +17

Impact of performance status and transfusion dependency on outcome of patients with myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia treated with azacitidine (PIAZA study)

Jürgen Wehmeyer, Christoph Losem, Stephan Schmitz et al. · European Journal Of Haematology · 2018 · 13 citations

Medicine, Pharmacology, Pharmacotherapy +17